`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`PROLLENIUM US INC.,
`Petitioner,
`v.
`ALLERGAN INDUSTRIE, SAS,
`Patent Owner.
`_____________
`
`Case IPR2020-00084
`U.S. Patent No. 9,089,519
`_____________
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`
`
`
`IPR2020-00084
`U.S. Patent No. 9,089,519
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Allergan Industrie, SAS (“Patent
`
`Owner”) hereby submits the following Mandatory Notices in response to the
`
`Petition for Inter Partes Review of U.S. Patent No. 9,089,519.
`
`I.
`
`Real Parties-in-Interest under 37 C.F.R. § 42.8(b)(1) (NO CHANGE)
`Each of Allergan Industrie, SAS; Allergan USA, Inc.; Allergan Sales, LLC;
`
`Allergan Holdings France SAS; Allergan Holdings Limited; Allergan Holdings,
`
`Inc.; Allergan Puerto Rico Holdings, Inc.; and Allergan, Inc. is a real party-in-
`
`interest in this proceeding.
`
`All of the named entities are indirect, wholly owned subsidiaries of AbbVie
`
`Inc., a publically traded company. Patent Owner does not concede that AbbVie
`
`Inc. is a real party-in-interest.
`
`II. Related Matters under 37 C.F.R. § 42.8(b)(2) (NO CHANGE)
`The follow judicial or administrative matters may affect or be affected by a
`
`decision in this proceeding:
`
`• Allergan USA, Inc. and Allergan Industrie, SAS v. Prollenium US Inc. and
`
`Prollenium Medical Techs. Inc., No. 19-cv-00126-CFC (D. Del.).
`
`• Allergan USA, Inc. and Allergan Industrie, SAS v. Prollenium US Inc. and
`
`Prollenium Medical Techs. Inc., No. 20-cv-00104-CFC (D. Del.).
`
`• Prollenium US Inc. v. Allergan Industrie, SAS, IPR2019-01508 (petition for
`
`inter partes review of U.S. Patent No. 9,238,013 filed August 23, 2019).
`
`
`
`1
`
`
`
`IPR2020-00084
`U.S. Patent No. 9,089,519
`
`• Prollenium US Inc. v. Allergan Industrie, SAS, IPR2019-01505 (petition for
`
`inter partes review of U.S. Patent No. 8,450,475 filed September 3, 2019).
`
`• Prollenium US Inc. v. Allergan Industrie, SAS, IPR2019-01509 (petition for
`
`inter partes review of U.S. Patent No. 9,358,322 filed September 3, 2019).
`
`• Prollenium US Inc. v. Allergan Industrie, SAS, IPR2019-01617 (petition for
`
`inter partes review of U.S. Patent No. 8,822,676 filed September 16, 2019).
`
`• Prollenium US Inc. v. Allergan Industrie, SAS, IPR2019-01506 (petition for
`
`inter partes review of U.S. Patent No. 8,357,795 filed September 20, 2019).
`
`• Prollenium US Inc. v. Allergan Industrie, SAS, IPR2019-01632 (petition for
`
`inter partes review of U.S. Patent No. 8,357,795 filed September 20, 2019).
`
`• Prollenium US Inc. v. Allergan Industrie, SAS, IPR2019-00901 (petition for
`
`inter partes review of U.S. Patent No. 10,485,896 filed June 2, 2020).
`
`• Prollenium US Inc. v. Allergan Industrie, SAS, IPR2019-00902 (petition for
`
`inter partes review of U.S. Patent No. 10,391,202 filed June 2, 2020).
`
`III. Lead and Back-Up Counsel and Service Information under 37 C.F.R.
`§ 42.8(b)(3)–(4) (NEW)
`Patent Owner designates the following lead and back-up counsel with
`
`corresponding service information. Patent Owner consents to electronic service by
`
`email at the email addresses provided.
`
`
`
`
`
`2
`
`
`
`IPR2020-00084
`U.S. Patent No. 9,089,519
`
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel.: (858) 314-1200
`Fax.: (844) 345-3178
`Email: aminsogna@jonesday.com
`
`Tamera M. Weisser, Ph.D. (Reg. No. 47,856)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel.: (858) 314-1200
`Fax.: (844) 345-3178
`Email: tweisser@jonesday.com
`
`S. Christian Platt (Reg. No. 46,998)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel.: (858) 314-1200
`Fax.: (844) 345-3178
`Email: cplatt@jonesday.com
`
`Sarah A. Geers (Reg. No. 69,123)
`Jones Day
`250 Vesey Street
`New York, NY 10281
`Tel.: (212) 326-3939
`Fax.: (212) 755-7306
`Email: sgeers@jonesday.com
`
`Jennifer M. Hartjes (Reg. No. 77,687)
`Jones Day
`90 S 7th Street
`Minneapolis, MN 55402
`Tel.: (612) 217-8914
`Fax.: (844) 345-3178
`Email: jhartjes@jonesday.com
`3
`
`Lead Counsel:
`
`First Back-up Counsel:
`
`Back-up Counsel:
`
`
`
`
`
`
`
`Dated: July 15, 2020
`
`
`IPR2020-00084
`U.S. Patent No. 9,089,519
`
`
`Respectfully Submitted,
`
`/s/ Anthony M. Insogna
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel.: (858) 314-1200
`Fax.: (844) 345-3178
`
`Attorney for Patent Owner
`
`4
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of Patent Owner’s Updated
`
`Mandatory Notices by electronic means at the following address of record:
`
`mcc.prollenium.ipr@mcciplaw.com
`
`Dated: July 15, 2020
`
`
`/s/ Anthony M. Insogna
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel.: (858) 314-1200
`Fax.: (844) 345-3178
`
`Attorney for Patent Owner
`
`
`
`
`
`
`
`